Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia / Maurizio Fava en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 137-147 Título : Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia Tipo de documento: texto impreso Autores: Maurizio Fava, Autor ; Sharon L. Hoog, Autor ; Rajinder A. Judge, Autor Fecha de publicación: 2023 Artículo en la página: pp. 137-147 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Trastorno Depresivo Mayor, Fluoxetina, Paroxetina, Sertralina, Trastornos del sueño. Resumen: This study assessed whether fluoxetine, sertraline, and paroxetine differ in efficacy and tolerability in depressed patients and the impact of baseline insomnia on outcomes. Patients (N = 284) with DSM-IV major depressive disorder were randomly assigned in a double-blind fashion to fluoxetine, paroxetine, or sertraline for 10 to 16 weeks of treatment. Link: ./index.php?lvl=notice_display&id=31078 [artículo] Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia [texto impreso] / Maurizio Fava, Autor ; Sharon L. Hoog, Autor ; Rajinder A. Judge, Autor . - 2023 . - pp. 137-147. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 137-147 Palabras clave: Antidepresivos, Trastorno Depresivo Mayor, Fluoxetina, Paroxetina, Sertralina, Trastornos del sueño. Resumen: This study assessed whether fluoxetine, sertraline, and paroxetine differ in efficacy and tolerability in depressed patients and the impact of baseline insomnia on outcomes. Patients (N = 284) with DSM-IV major depressive disorder were randomly assigned in a double-blind fashion to fluoxetine, paroxetine, or sertraline for 10 to 16 weeks of treatment. Link: ./index.php?lvl=notice_display&id=31078

Changes in energy during treatment of depression: an analysis of fluoxetine in double-blind, placebo-controlled trials / Rajinder A. Judge en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 6 (Diciembre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 6 (Diciembre) . - pp. 666-672 Título : Changes in energy during treatment of depression: an analysis of fluoxetine in double-blind, placebo-controlled trials Tipo de documento: texto impreso Autores: Rajinder A. Judge, Autor ; John M. Plewes, Autor ; Vinod Kumar, Autor Fecha de publicación: 2023 Artículo en la página: pp. 666-672 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Ensayos clínicos controlados, Trastorno depresivo mayor, Fatiga, Fluoxetina. Resumen: More than two thirds of patients with depression present with symptoms of fatigue, low energy, and listlessness. Because daytime sedation may be a concern in such patients, a "nonsedating" antidepressant should be considered. The authors examined the effects of fluoxetine on depression-related disturbances in energy. Link: ./index.php?lvl=notice_display&id=31158 [artículo] Changes in energy during treatment of depression: an analysis of fluoxetine in double-blind, placebo-controlled trials [texto impreso] / Rajinder A. Judge, Autor ; John M. Plewes, Autor ; Vinod Kumar, Autor . - 2023 . - pp. 666-672. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 6 (Diciembre) . - pp. 666-672 Palabras clave: Ensayos clínicos controlados, Trastorno depresivo mayor, Fatiga, Fluoxetina. Resumen: More than two thirds of patients with depression present with symptoms of fatigue, low energy, and listlessness. Because daytime sedation may be a concern in such patients, a "nonsedating" antidepressant should be considered. The authors examined the effects of fluoxetine on depression-related disturbances in energy. Link: ./index.php?lvl=notice_display&id=31158

---

1 (1 - 2 / 2)